台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    43.20
  • 漲跌
    ▼0.35
  • 漲幅
    -0.80%
  • 成交量
    75
  • 產業
    上市 生技醫療類股
  • 128人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
和康生 (1783)籌碼相關-港商法國興業 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

港商法國興業 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/03/2000.000.344.9044.90-0.3167-0.19%
2024/02/231047.6500.0046.90101795.57%
2024/02/221047.5300.0047.50101835.44%
2024/01/22844.9800.0045.0581884.25%
2023/12/271148.5000.0048.25112314.75%
2023/12/19847.9200.0047.7582313.46%
2023/12/151048.4900.0048.60102304.34%
2023/10/31848.5500.0046.9583262.45%
2023/10/17847.8400.0047.4086711.19%
2023/08/241355.5700.0055.30131,3210.98%
2023/08/1500.00157.8057.50-11,458-0.07%
2023/07/1200.00163.0060.60-12,175-0.05%
2023/05/1000.00966.7467.10-92,800-0.32%
2023/05/0500.002170.1071.50-213,380-0.62%
2023/05/0400.001769.3069.30-173,167-0.54%
2023/05/0300.00163.7063.00-13,104-0.03%
2023/04/2800.00461.5361.70-43,075-0.13%
2023/04/2100.00761.8058.10-73,187-0.22%
2023/04/201264.85662.2059.7063,1520.19%
2023/04/07256.8000.0056.5023,2500.06%
2023/04/06155.7000.0056.5013,5310.03%
2023/03/031065.9000.0065.90103,5350.28%
2023/02/222563.9000.0063.90253,2770.76%
2023/02/201462.7000.0062.70143,0710.46%
2022/07/2500.00845.5046.00-81,441-0.56%
2022/07/04941.9500.0040.1591,1560.78%
2022/06/3000.00848.9548.00-81,006-0.79%
2022/06/231042.4500.0041.05103692.71%
2022/01/2500.00243.1542.40-2594-0.34%
2022/01/24243.3800.0043.9526040.33%
2022/01/1700.00246.4547.05-2610-0.33%
2021/11/1700.00157.5057.50-1932-0.11%
2021/11/10253.0500.0054.2021,1380.18%
2021/10/2900.00151.4050.80-11,378-0.07%
2021/10/21153.60153.4052.8001,9110.00%
2021/10/15253.2500.0052.6022,0450.10%
2021/10/1200.00456.6354.00-42,137-0.19%
2021/10/07353.9000.0055.5032,2090.14%
2021/09/1600.00156.0057.00-12,193-0.05%
2021/09/10156.8000.0058.0012,1930.05%
2021/09/0900.00358.2059.20-32,185-0.14%
2021/09/0800.00358.9057.00-32,179-0.14%
2021/09/0700.00158.9060.10-12,159-0.05%
2021/09/03260.8000.0060.3022,1060.09%
2021/08/31163.6000.0063.6012,0680.05%
2021/08/27264.2000.0063.6022,0750.10%
2021/08/2600.00866.3564.80-82,077-0.39%
2021/08/23967.1000.0066.2092,0210.45%
2021/08/1900.00670.8870.90-61,914-0.31%
2021/08/18863.15764.4165.2012,0060.05%
2021/08/0300.00659.1562.50-61,923-0.31%
2021/08/021256.8200.0057.50121,8590.65%
2021/07/2800.00149.6049.65-11,541-0.06%
2021/07/2600.00443.3543.10-41,406-0.28%
2021/07/22339.6700.0039.8031,3740.22%
2021/07/1900.00740.0340.40-71,219-0.57%
2021/07/13837.8400.0037.2581,2510.64%
2021/06/28135.6500.0035.6011,2680.08%
2021/06/2100.00135.0535.05-11,439-0.07%
2021/06/15135.4500.0034.8511,5180.07%
2021/05/2700.00436.0535.80-41,510-0.26%
2021/05/25134.1000.0035.5011,3100.08%
2021/05/21332.05133.0533.9521,2410.16%
2021/05/2000.00131.8532.15-11,226-0.08%
2021/05/17432.20232.3033.7021,1890.17%
2021/05/12533.09533.0333.4501,0490.00%
2021/05/1100.00132.3032.00-11,001-0.10%
2021/05/0500.00231.9032.05-2990-0.20%
2021/05/04331.6800.0031.1539850.30%
2021/04/2100.00535.1535.00-5904-0.55%
2021/04/14331.4000.0032.2037090.42%
2021/04/13233.3000.0032.5026950.29%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章